NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Trip.com Group Limited ("Trip.com" or the "Company") (NASDAQ:TCOM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Trip.com and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of PDD Holdings Inc. ("PDD" or the "Company") (NASDAQ:PDD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PDD and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of First Citizens BancShares, Inc. ("First Citizens" or the "Company") (NASDAQ:FCNCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether First Citizens and certain of
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of REGENXBIO Inc. ("Regenxbio" or the "Company") (NASDAQ:RGNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Regenxbio and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Capital One Financial Corporation ("Capital One" or the "Company") (NYSE:COF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Capital One and certain of
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Wealthfront Corporation ("Wealthfront" or the "Company") (NASDAQ:WLTH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Wealthfront and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Apollo Global Management, Inc. ("Apollo" or the "Company") (NYSE:APO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Apollo and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ:AQST). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aquestive and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Ashford Hospitality Trust, Inc. ("Ashford" or the "Company") (NYSE:AHT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ashford and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2026 / Pomerantz LLP is investigating claims on behalf of investors of Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ:SGML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Sigma Lithium and certain of its